Natural products as angiogenesis modulators

被引：20
作者：
El Sayed, KA [1 ]
机构：
[1] Univ Louisiana Monore, Sch Pharm, Dept Basic Pharmaceut Sci, Monore, LA 71209 USA
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2005年 / 5卷 / 11期
关键词：
cancer; angiogenesis modulators; plant; marine; microbial natural products;
D O I：
10.2174/138955705774575291
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Cancer remains one of the major causes of death worldwide. Anti-angiogenic therapy is one of the new approaches to anticancer therapy. Out of 22 angiogenesis inhibitors currently under clinical trials there are 11 natural products or were modeled on a natural product parent. This review shows the potential of natural products for the discovery of new anti-angiogenic leads.
引用
收藏
页码：971 / 993
页数：23
相关论文
共 165 条
[41]   The rationale and future potential of angiogenesis inhibitors in neoplasia [J].
Gasparini, G .
DRUGS, 1999, 58 (01) :17-38
[42]   Staurosporine analogues - pharmacological toys or useful antitumour agents? [J].
Gescher, A .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2000, 34 (02) :127-135
[43]  
Gingras D, 2001, ANTICANCER RES, V21, P145
[44]   Neovastat -: a novel antiangiogenic drug for cancer therapy [J].
Ginqras, D ;
Boivin, D ;
Deckers, C ;
Gendron, SA ;
Barthomeuf, C ;
Bébliveau, R .
ANTI-CANCER DRUGS, 2003, 14 (02) :91-96
[45]   Targeting tumour vasculature: the development of combretastatin A4 [J].
Griggs, Jeremy ;
Metcalfe, James C. ;
Hesketh, Robin .
LANCET ONCOLOGY, 2001, 2 (02) :82-87
[46]  
Hao D, 2003, CLIN CANCER RES, V9, P2465
[47]  
Hayot C, 2002, INT J ONCOL, V21, P417
[48]  
Hill SA, 2002, ANTICANCER RES, V22, P1453
[49]   Schedule dependence of combretastatin A4 phosphate in transplanted and spontaneous tumour models [J].
Hill, SA ;
Chaplin, DJ ;
Lewis, G ;
Tozer, GM .
INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (01) :70-74
[50]  
HU DE, 1995, LAB INVEST, V72, P601
12345678910